Profil
Dvorit Samid currently works at Aardvark Therapeutics, Inc., as Executive Vice President-Medical Affairs.
Dr. Samid also formerly worked at Synta Pharmaceuticals Corp., as Vice President-Medical Affairs and NantKwest, Inc., as Senior Vice President-Medical Affairs.
Dr. Samid received her doctorate degree from The Catholic University of America and undergraduate degree from The Hebrew University of Jerusalem.
Postes actifs de Dvorit Samid
| Sociétés | Poste | Début |
|---|---|---|
| AARDVARK THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Dvorit Samid
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNITYBIO, INC. | Directeur Technique/Scientifique/R&D | - |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Directeur Technique/Scientifique/R&D | - |
Formation de Dvorit Samid
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Health Technology |
NantKwest, Inc.
NantKwest, Inc. BiotechnologyHealth Technology Develops and produces cancer treatment products | Health Technology |
The Catholic University of America
The Catholic University of America Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aardvark Therapeutics, Inc.
Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics for obesity and metabolic diseases | Health Technology |
















